Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 16/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 9/20 | 0.58 |
| ▸ | ADORA2A | P29274 | 8/20 | 0.58 |
| ▸ | ADORA2B | P29275 | 6/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | HTR2B | P41595 | 1/20 | 0.49 |
| ▸ | PPARD | Q03181 | 1/20 | 0.49 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL7232089 | 0.97 | ADORA3 (0.55) | ADORA3ADORA1ADORA2AADORA2BHTR2C | |
| SCHEMBL7232094 | 0.91 | ADORA3 (0.50) | ADORA3ADORA1ADORA2AADORA2BHTR2C | |
| SCHEMBL5086039 | 0.87 | ADORA2A (0.49) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL7455168 | 0.85 | ADORA3 (0.47) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL5088919 | 0.85 | ADORA3 (0.63) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL7459232 | 0.84 | ADORA3 (0.52) | ADORA3ADORA1ADORA2AADORA2BCYP1A2 | |
| Formic Acid SCHEMBL7231158 | 0.84 | ADORA2A (0.48) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL7456601 | 0.83 | ADORA3 (0.58) | ADORA3ADORA1ADORA2AADORA2B | |
| Formic Acid SCHEMBL7231574 | 0.82 | ADORA3 (0.60) | ADORA3ADORA1ADORA2AADORA2B | |
| Formic Acid SCHEMBL7221846 | 0.82 | ADORA3 (0.44) | ADORA3ADORA1ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4156035-B2 | — | — | 2008-09-24 | — | — | JP | claimed |
| EP-0948509-B1 | 2-(PURIN-9-YL)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES | GLAXO GROUP LTD (GB) | 2002-10-16 | — | — | EP | claimed |
| US-6426337-B1 | ANTIINFLAMMATORY AGENTS | SMITHKLINE BEECHAM CORPORATION | 2002-07-30 | — | — | US | claimed |
| JP-2001506668-A | — | — | 2001-05-22 | — | — | JP | claimed |
| EP-0948509-A1 | 2-(PURIN-9-YL)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES | GLAXO GROUP LIMITED (GB) | 1999-10-13 | — | — | EP | claimed |
| WO-1998028319-A1 | 2-(PURIN-9-YL)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES | GLAXO GROUP LIMITED (GB) | 1998-07-02 | — | — | WO | claimed |